Related Experiment Videos
Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism
A B Grey1, J P Stapleton, M C Evans
1Department of Medicine, University of Auckland, New Zealand.
Clinical Endocrinology
|June 1, 1996
Summary
Mild primary hyperparathyroidism accelerates bone loss in postmenopausal women, increasing osteopenia risk. Skeletal monitoring is recommended for early detection and intervention in these patients.
Area of Science:
- Endocrinology
- Bone Metabolism
- Geriatric Medicine
Background:
- Osteopenia is a recognized complication of primary hyperparathyroidism, prompting parathyroidectomy.
- The skeletal impact of mild, asymptomatic primary hyperparathyroidism remains unclear.
- Understanding bone loss rates is crucial for managing postmenopausal women with this condition.
Purpose of the Study:
- To investigate the effect of mild primary hyperparathyroidism on bone loss rates in postmenopausal women.
- To compare skeletal changes in women with untreated mild primary hyperparathyroidism versus age-matched controls.
Main Methods:
- Prospective study comparing 17 postmenopausal women with mild primary hyperparathyroidism to 48 age-matched controls over two years.
- Bone mineral density (BMD) changes were assessed throughout the skeleton.
Main Results:
- Women with primary hyperparathyroidism exhibited significantly higher annual bone mineral density loss in the total body (P=0.04) and spine (P=0.02).
- A trend towards lumbar spine bone loss was observed in the primary hyperparathyroidism group, unlike controls.
- No significant differences in bone loss rates were found in the legs or proximal femur.
Conclusions:
- Primary hyperparathyroidism is linked to accelerated total body bone mineral density loss in postmenopausal women.
- Prolonged disease duration may increase osteopenia risk.
- Regular skeletal monitoring and bone loss interventions are advisable for affected individuals.